Filed: 5/15/2026ACC: 0001193125-26-225423
📋 What this filing means
FCPM III SERVICES B.V. filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $722.21M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$722.21M
Total AUM (reported)
44.09M
Total Shares
Allocation by class
ORDINARY SHARES$294.46M40.8%
COM$267.70M37.1%
COM NEW$136.68M18.9%
SPONSORED ADS$16.09M2.2%
W EXP 10/31/2028$7.28M1.0%
Portfolio Concentration
Top 3$452.11M62.6%
4–10$270.09M37.4%
Top 3 weight
62.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 44.09M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
44.09M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other10
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings10
Rows:
NEWAMSTERDAM PHARMA COMPANY
DFNDShares9.20M
TypeSH
Market value$294.46M
40.77%
Sole
0.00
Shared
9.20M
None
0.00
DYNE THERAPEUTICS INC
DFNDShares4.64M
TypeSH
Market value$84.20M
11.66%
Sole
0.00
Shared
4.64M
None
0.00
VOR BIOPHARMA INC
DFNDShares4.12M
TypeSH
Market value$73.45M
10.17%
Sole
0.00
Shared
4.12M
None
0.00
ENGENE HOLDINGS INC
DFNDShares9.63M
TypeSH
Market value$65.60M
9.08%
Sole
0.00
Shared
9.63M
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares3.23M
TypeSH
Market value$65.59M
9.08%
Sole
0.00
Shared
3.23M
None
0.00
DAMORA THERAPEUTICS INC
DFNDShares2.44M
TypeSH
Market value$63.22M
8.75%
Sole
0.00
Shared
2.44M
None
0.00
CRESCENT BIOPHARMA INC.
DFNDShares1.68M
TypeSH
Market value$30.82M
4.27%
Sole
0.00
Shared
1.68M
None
0.00
REPLIMUNE GROUP INC
DFNDShares2.81M
TypeSH
Market value$21.48M
2.97%
Sole
0.00
Shared
2.81M
None
0.00
BICYCLE THERAPEUTICS PLC
DFNDShares3.47M
TypeSH
Market value$16.09M
2.23%
Sole
0.00
Shared
3.47M
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.88M
TypeSH
Market value$7.28M
1.01%
Sole
0.00
Shared
2.88M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 9.20M | SH | $294.46M 40.77% | 0.00 | 9.20M | 0.00 |
DYNE THERAPEUTICS INCDFND | COM | 4.64M | SH | $84.20M 11.66% | 0.00 | 4.64M | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 4.12M | SH | $73.45M 10.17% | 0.00 | 4.12M | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 9.63M | SH | $65.60M 9.08% | 0.00 | 9.63M | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 3.23M | SH | $65.59M 9.08% | 0.00 | 3.23M | 0.00 |
DAMORA THERAPEUTICS INCDFND | COM NEW | 2.44M | SH | $63.22M 8.75% | 0.00 | 2.44M | 0.00 |
CRESCENT BIOPHARMA INC.DFND | COM | 1.68M | SH | $30.82M 4.27% | 0.00 | 1.68M | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 2.81M | SH | $21.48M 2.97% | 0.00 | 2.81M | 0.00 |
BICYCLE THERAPEUTICS PLCDFND | SPONSORED ADS | 3.47M | SH | $16.09M 2.23% | 0.00 | 3.47M | 0.00 |
ENGENE HOLDINGS INCDFND | W EXP 10/31/2028 | 2.88M | SH | $7.28M 1.01% | 0.00 | 2.88M | 0.00 |